TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 191 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2021. The put-call ratio across all filers is 1.80 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,123,000 | +375.8% | 14,921 | +201.1% | 0.00% | – |
| Q4 2021 | $236,000 | -54.4% | 4,956 | -36.3% | 0.00% | -100.0% |
| Q3 2021 | $517,000 | +19.1% | 7,779 | +69.6% | 0.00% | 0.0% |
| Q1 2021 | $434,000 | +30.3% | 4,587 | +68.1% | 0.00% | 0.0% |
| Q4 2020 | $333,000 | -59.9% | 2,729 | -78.8% | 0.00% | 0.0% |
| Q2 2020 | $830,000 | – | 12,853 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| venBio Partners LLC | 708,233 | $44,116,000 | 18.91% |
| Corriente Advisors, LLC | 285,000 | $17,753,000 | 9.54% |
| Cormorant Asset Management, LP | 3,396,650 | $211,577,000 | 8.44% |
| Opaleye Management Inc. | 340,500 | $21,210,000 | 4.16% |
| Orbimed Advisors | 2,745,327 | $171,006,000 | 2.44% |
| Parkman Healthcare Partners LLC | 101,434 | $6,318,000 | 1.82% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 35,000 | $2,179,000 | 0.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 366,000 | $22,798,000 | 0.73% |
| Artal Group S.A. | 300,000 | $18,687,000 | 0.72% |
| DAFNA Capital Management LLC | 30,408 | $1,894,000 | 0.65% |